Orange Book product · Brand (NDA)
NURTEC ODT
RIMEGEPANT SULFATE
At a glance
Feb 27, 2020
Approved
Brand (NDA)
Application
Not listed
TE code
5
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 27, 2020
6 yr 5 mo ago
Today
Patent 8759372 expires
Listed drug substance patent expiration.
Feb 25, 2033
in 6 yr 9 mo
Patent 8314117 expires
Listed drug substance patent expiration.
Feb 27, 2034
in 7 yr 10 mo
Patent 8314117 expires
Listed drug substance patent expiration.
Feb 27, 2034
in 7 yr 10 mo
Patent 11083724 expires
Listed drug product patent expiration.
Mar 25, 2039
in 12 yr 11 mo
Patent 11083724 expires
Listed drug product patent expiration.
Mar 25, 2039
in 12 yr 11 mo
Pharmaceutical detail
Active ingredient
RIMEGEPANT SULFATE
Strength
EQ 75MG BASE
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
TE code
Not listed
Application
NDA 212728
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (5)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8759372 | Feb 25, 2033 | in 6 yr 9 mo | SubstanceProduct |
| 8314117 | Feb 27, 2034 | in 7 yr 10 mo | SubstanceProductU-2718 |
| 8314117 | Feb 27, 2034 | in 7 yr 10 mo | SubstanceProductU-3142 |
| 11083724 | Mar 25, 2039 | in 12 yr 11 mo | ProductU-2718 |
| 11083724 | Mar 25, 2039 | in 12 yr 11 mo | ProductU-3142 |
